Research output per year
Research output per year
Personal profile
Headline
ASSISTANT PROFESSOR | Medicine, Infectious Diseases
Biography
Dr. Liu earned his PhD at Princeton University studying human cytomegalovirus in the laboratory of Dr. Thomas Shenk. His post-doctoral training was at the Icahn School of Medicine at Mount Sinai developing universal influenza vaccine candidates under the guidance of Dr. Peter Palese. He completed his infectious disease fellowship at the Icahn School of Medicine at Mount Sinai. He is an ABIM Board Certified physician in internal medicine and infectious diseases.
Since March 2020, Sean helped to establish the convalescent plasma treatment program at the Mount Sinai Hospital as well as coordinate multiple COVID-19 clinical studies.
Fingerprint
Dive into the research topics where Sean Liu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 8 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Nirmatrelvir–ritonavir targeting viral persistence in post-COVID-19 condition (long COVID) in the USA (RECOVER-VITAL): a randomised, double-blind, placebo-controlled, phase 2 trial
RECOVER-VITAL Clinical Trial Group, 2026, (Accepted/In press) In: The Lancet Infectious Diseases.Research output: Contribution to journal › Article › peer-review
Open Access -
Phase 1 trial of intranasal NDV-HXP-S in previously vaccinated adults
Liu, S. T. H., González-Domínguez, I., Martínez-Pérez, A., Bozkus, C. C., Bladh, O., Broomes-Pennicott, T., Jen, A., Egan, E., Leiva-Ortiz, E., Abid, A., Aguilera, K., Åberg, M., Bhavsar, D., Yellin, T., Abbad, A., Singh, G., Carreño, J. M., Adams, J., Quigley, C. & Saxena, M. & 9 others, , 30 Aug 2026, In: Vaccine. 89, 128870.Research output: Contribution to journal › Article › peer-review
Open Access -
Alzheimer's disease-associated CD83(+) microglia are linked with increased immunoglobulin G4 and human cytomegalovirus in the gut, vagal nerve, and brain
Readhead, B. P., Mastroeni, D. F., Wang, Q., Sierra, M. A., de Ávila, C., Jimoh, T. O., Haure-Mirande, J. V., Atanasoff, K. E., Nolz, J., Suazo, C., Barton, N. J., Orszulak, A. R., Chigas, S. M., Tran, K., Mirza, A., Ryon, K., Proszynski, J., Najjar, D., Dudley, J. T. & Liu, S. T. H. & 21 others, , Jan 2025, In: Alzheimer's and Dementia. 21, 1, e14401.Research output: Contribution to journal › Article › peer-review
Open Access -
Extended nirmatrelvir–ritonavir treatment durations for immunocompromised patients with COVID-19 (EPIC-IC): a placebo-controlled, randomised, double-blind, phase 2 trial
Weinstein, E., Paredes, R., Gardner, A., Almas, M., Baniecki, M. L., Guan, S., Tudone, E., Antonucci, S., Gregg, K., Garcia-Vidal, C., Camacho-Ortiz, A., Wisemandle, W., Terra, S. G., Liu, S., Aberg, J. A., Rana, M. M., Corey, L., Ford, E. S., Hammond, J. & Rusnak, J., Nov 2025, In: The Lancet Infectious Diseases. 25, 11, p. 1243-1253 11 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Impact of Baseline SARS-CoV-2 Load in Plasma and Upper Airways on the Incidence of Acute Extrapulmonary Complications of COVID-19: A Multicentric, Prospective, Cohort Study
Jensen, T. O., Harper, K., Gupta, S., Liu, S. T., Dharan, N. J., Baker, J. V., Pett, S. L., Shaw-Saliba, K., Esmail, A., Ho, M. Q., Almasri, E., Dewar, R. L., Lundgren, J. & Vock, D. M., 15 Dec 2024, In: Clinical Infectious Diseases. 79, 6, p. 1394-1403 10 p.Research output: Contribution to journal › Article › peer-review
Open Access